Autoantibodies to Amyloid β-Peptide (Aβ) are Increased in Alzheimer’s Disease Patients and Aβ Antibodies Can Enhance Aβ Neurotoxicity: Implications for Disease Pathogenesis and Vaccine Development

By Nath Avindra   Hall Elizabeth   Tuzova Marnia   Dobbs Michael   Jones Melina   Anderson Caroline   Woodward Jerold   Guo Zhihong   Fu Weiming   Kryscio Richard   Wekstein David   Smith Charles   Markesbery William R.   Mattson Mark P.  

NeuroMolecular Medicine, Vol. 3, Iss. 1, 2003-02 ,pp. : 29-40

Humana Press, Inc

Access to resources Recommend Favorite

Cerebrospinal fluid levels of phosphorylated tau and Aβ1-38/Aβ1-40/Aβ1-42 in Alzheimer's disease with PS1 mutations

By Ikeda Masaki  

Amyloid: The Journal of Protein Folding Disorders, Vol. 20, Iss. 2, 2013-06 ,pp. : 107-112

Informa Healthcare

Access to resources Recommend Favorite

Role of the Region 23-28 in A&bgr; Fibril Formation: Insights from Simulations of the Monomers and Dimers of Alzheimer's Peptides A&bgr;40 and A&bgr;42

By  

Current Alzheimer Research, Vol. 5, Iss. 3, 2008-06 ,pp. : 244-250

Bentham Science Publishers

Access to resources Recommend Favorite

Aβ Oligomer-Induced Synapse Degeneration in Alzheimer's Disease

By Wilcox Kyle  

Cellular and Molecular Neurobiology, Vol. 31, Iss. 6, 2011-08 ,pp. : 939-948

Springer Publishing Company

Access to resources Recommend Favorite

Per-6-Substituted β-Cyclodextrin Libraries Inhibit Formation of β-Amyloid-Peptide (Aβ)-Derived, Soluble Oligomers

By Yu Jiaxin   Bakhos Lara   Chang Lei   Holterman Mark J.   Klein William L.   Venton Duane L.  

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 51-56

Humana Press, Inc

Access to resources Recommend Favorite